BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11131913)

  • 1. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.
    Feltis BA; Wiesner SM; Kim AS; Erlandsen SL; Lyerly DL; Wilkins TD; Wells CL
    Shock; 2000 Dec; 14(6):629-34. PubMed ID: 11131913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium.
    Feltis BA; Kim AS; Kinneberg KM; Lyerly DL; Wilkins TD; Erlandsen SL; Wells CL
    Arch Surg; 1999 Nov; 134(11):1235-41; discussion 1241-2. PubMed ID: 10555639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
    Feltis BA; Garni RM; Wells CL
    J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tumor necrosis factor alpha, interferon gamma, and interleukin-4 on bacteria-enterocyte interactions.
    Hess DJ; Henry-Stanley MJ; Erickson EA; Wells CL
    J Surg Res; 2002 May; 104(2):88-94. PubMed ID: 12020125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.
    Savidge TC; Pan WH; Newman P; O'brien M; Anton PM; Pothoulakis C
    Gastroenterology; 2003 Aug; 125(2):413-20. PubMed ID: 12891543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes.
    Wells CL; van de Westerlo EM; Jechorek RP; Feltis BA; Wilkins TD; Erlandsen SL
    Gastroenterology; 1996 May; 110(5):1429-37. PubMed ID: 8613048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular survival of Staphylococcus aureus within cultured enterocytes.
    Hess DJ; Henry-Stanley MJ; Erickson EA; Wells CL
    J Surg Res; 2003 Sep; 114(1):42-9. PubMed ID: 13678697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
    Riegler M; Sedivy R; Pothoulakis C; Hamilton G; Zacherl J; Bischof G; Cosentini E; Feil W; Schiessel R; LaMont JT
    J Clin Invest; 1995 May; 95(5):2004-11. PubMed ID: 7738167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.
    Lamont JT
    Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
    Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
    Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity in culture of epithelial cells from rhesus monkey kidney and human colon carcinoma to toxins A and B from Clostridium difficile.
    Torres J; Camorlinga-Ponce M; Muñoz O
    Toxicon; 1992 Apr; 30(4):419-26. PubMed ID: 1626323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
    Olson A; Diebel LN; Liberati DM
    J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin expression, enterocyte maturation, and bacterial internalization.
    Hess DJ; Henry-Stanley MJ; Moore EA; Wells CL
    J Surg Res; 2001 Jun; 98(2):116-22. PubMed ID: 11397127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective.
    McConnie R; Kastl A
    Curr Gastroenterol Rep; 2017 Aug; 19(8):34. PubMed ID: 28707191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive domain of Clostridium difficile toxin B exhibits cytotoxic effects on human intestinal epithelial cells and decreases epithelial barrier function.
    Zemljic M; Rupnik M; Scarpa M; Anderluh G; Palù G; Castagliuolo I
    Anaerobe; 2010 Oct; 16(5):527-32. PubMed ID: 20620216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile toxins facilitate bacterial colonization by modulating the fence and gate function of colonic epithelium.
    Kasendra M; Barrile R; Leuzzi R; Soriani M
    J Infect Dis; 2014 Apr; 209(7):1095-104. PubMed ID: 24273043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of increased permeability of polarized enterocyte monolayers by enterotoxigenic Escherichia coli heat-labile enterotoxin.
    Kreisberg RB; Harper J; Strauman MC; Marohn M; Clements JD; Nataro JP
    Am J Trop Med Hyg; 2011 Mar; 84(3):451-5. PubMed ID: 21363985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical.
    Canny G; Drudy D; Macmathuna P; O'farrelly C; Baird AW
    Life Sci; 2006 Jan; 78(9):920-5. PubMed ID: 16185718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of host defenses on Clostridium difficile toxin-induced intestinal barrier injury.
    Olson A; Diebel LN; Liberati DM
    J Trauma Acute Care Surg; 2013 Apr; 74(4):983-89; discussion 989-90. PubMed ID: 23511135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.